Literature DB >> 15547049

Saturable distribution of tacrine into the striatal extracellular fluid of the rat: evidence of involvement of multiple organic cation transporters in the transport.

Jong-Hyuk Sung1, Kyung-Ha Yu, Jin-Sun Park, Takashi Tsuruo, Dae-Duk Kim, Chang-Koo Shim, Suk-Jae Chung.   

Abstract

The kinetics and mechanism by which tacrine is distributed in the rat brain were examined. Tacrine levels in plasma and striatal extracellular fluid were used to evaluate the pharmacokinetics of this process. The K(D,brain) was decreased with the dose for tacrine, indicating that the distribution to the brain is saturable. The uptake of organic cations such as choline, 1-methyl-4-phenylpyridinium (MPP), tetraethylammonium (TEA), and carnitine was inhibited by the addition of tacrine to cultures of mouse immortalized brain capillary endothelial cells. In addition, the apical to basal transport and basal to apical transport of tacrine were inhibited by the addition of organic cations to cultures of LLC-PK1 cells, suggesting that tacrine transport across the blood-brain barrier (BBB) is mediated by organic cation transport system(s). Consistent with the in vitro results, a standard reverse transcription-polymerase chain reaction procedure was able to amplify the message of mOCT2 and mOCTN2, but not mOCT1, in MBEC4 (mouse brain microvessel endothelial cell line 4) cells. Similarly, mRNAs for rOCT2 and rOCTN2 were present in representative rat brain samples. To determine whether OCT2 and/or OCTN2 transport tacrine, these transporters were cloned and then transfected in SK-HEP1 and HEK 293 cells. The uptake of choline, MPP, and TEA was inhibited by the presence of tacrine in rOCT2-expressing SK-HEP1 cells, whereas the uptake of carnitine was inhibited by the presence of tacrine in rOCTN2-expressing HEK 293 cells. Collectively, these observations suggest that the transport of tacrine across the BBB is mediated, at least in part, by multiple organic cation transport systems in rats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15547049     DOI: 10.1124/dmd.104.002220

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  9 in total

1.  Decreased expression of organic cation transporters, Oct1 and Oct2, in brain microvessels and its implication to MPTP-induced dopaminergic toxicity in aged mice.

Authors:  Kuo-Chen Wu; Ya-Hsuan Lu; Yi-Hsuan Peng; Ting-Fen Tsai; Yu-Han Kao; Hui-Ting Yang; Chun-Jung Lin
Journal:  J Cereb Blood Flow Metab       Date:  2014-09-24       Impact factor: 6.200

2.  Physiologically based pharmacokinetic modeling of SNU-0039, an anti-Alzheimer's agent, in rats.

Authors:  Kyeong-Ryoon Lee; Yoon-Jee Chae; Han-Joo Maeng; Jeewoo Lee; Dae-Duk Kim; Saeho Chong; Chang-Koo Shim; Suk-Jae Chung
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-08-25       Impact factor: 2.745

3.  Quantitative structure activity relationship for inhibition of human organic cation/carnitine transporter.

Authors:  Lei Diao; Sean Ekins; James E Polli
Journal:  Mol Pharm       Date:  2010-09-29       Impact factor: 4.939

4.  Pharmacokinetic interaction between DA-8159, a new erectogenic, and metformin in rats: competitive inhibition of metabolism via hepatic CYP3A1/2.

Authors:  Y H Choi; S J Chung; M G Lee
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

5.  Tacrine sinusoidal uptake and biliary excretion in sandwich-cultured primary rat hepatocytes.

Authors:  Loqman A Mohamed; Amal Kaddoumi
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

6.  Characteristics of L-citrulline transport through blood-brain barrier in the brain capillary endothelial cell line (TR-BBB cells).

Authors:  Kyeong-Eun Lee; Young-Sook Kang
Journal:  J Biomed Sci       Date:  2017-05-10       Impact factor: 8.410

Review 7.  Blood-Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke.

Authors:  Kelsy L Nilles; Erica I Williams; Robert D Betterton; Thomas P Davis; Patrick T Ronaldson
Journal:  Int J Mol Sci       Date:  2022-02-08       Impact factor: 5.923

Review 8.  Transport Mechanisms at the Blood-Brain Barrier and in Cellular Compartments of the Neurovascular Unit: Focus on CNS Delivery of Small Molecule Drugs.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Pharmaceutics       Date:  2022-07-20       Impact factor: 6.525

9.  Human Brain Microvascular Endothelial Cells Derived from the BC1 iPS Cell Line Exhibit a Blood-Brain Barrier Phenotype.

Authors:  Moriah E Katt; Zinnia S Xu; Sharon Gerecht; Peter C Searson
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.